Well that was before the Galaxy results got released. It's now quite clear why they've failed to secure a partner, no Pharma company wants to partner with Ganetespib once they take a look at the interim data. That was the missing piece investors didn't have until last week. Now the 1.5 year delay in securing a partner make sense. There isn't a blockbuster drug here, not even close.
1.5 years and counting. Promises of a partnership and nothing. Worse they made it sound like one was imminent just before the last public offering, and instead of delivering a partnership, they delivered dilution. The question is when the next round of dilution comes?